Viz.ai Wins 2023 Gold Edison Award™ for Innovation
Honored for excellence in innovation in AI Assisted Medicine SAN FRANCISCO – April 21, 2023 – Viz.ai, the leader in AI-powered...
Apr 21, 2023
All Resources
Explore our latest resources
Key Takeaways from ACC 2023
The American College of Cardiology’s Annual Scientific Session & Expo together with the World Congress of Cardiology – ACC.23/WCC –...
Apr 13, 2023
Viz.ai Named to Forbes AI 50 List of Top Artificial Intelligence Companies of...
Only company in healthcare to be recognized for the fourth time SAN FRANCISCO – April 12, 2023- Viz.ai, the leader...
Apr 12, 2023
April 6, 2023
Top 3 Takeaways from the Health Equity in Clinical Trials Congress
Panelists share their perspectives on how ethically trained AI can combat bias within the healthcare system, leading to greater access...
Mar 31, 2023
Viz.ai Launches Viz™ Trauma Suite to Support Change in Trauma Center Standards
Tailored for trauma care providers to help expedite patient care and improve outcomes SAN FRANCISCO--March 29, 2023 --Viz.ai, the leader...
Mar 29, 2023
Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal...
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms SAN FRANCISCO – March 21, 2023- Viz.ai, the leader...
Mar 21, 2023
Viz.ai Named One of Fierce Medtech’s “Fierce 15” Companies of 2022
Annual list recognizes innovative medtech companies that are advancing the art and science of healthcare SAN FRANCISCO – March 20,...
Mar 20, 2023